SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+61.82%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$457M
AUM Growth
+$457M
(+1.3%)
Cap. Flow
-$83.6M
Cap. Flow
% of AUM
-18.3%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
114
New
24
Increased
11
Reduced
44
Closed
23
Top Buys
| 1 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$15.5M |
| 2 |
AstraZeneca
AZN
|
$13.1M |
| 3 |
Universal Health Services
UHS
|
$11.1M |
| 4 |
Sanofi
SNY
|
$10.7M |
| 5 |
Amgen
AMGN
|
$9.2M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$17M |
| 2 |
McKesson
MCK
|
$12.3M |
| 3 |
Molina Healthcare
MOH
|
$10M |
| 4 |
AMN Healthcare
AMN
|
$9.67M |
| 5 |
Cardinal Health
CAH
|
$8.96M |
Sector Composition
| 1 | Healthcare | 87.36% |
| 2 | Technology | 1.15% |
| 3 | Consumer Staples | 0.82% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Curis
CRIS
$20.9M
| $39M | 7.97% | 4,756,438 -193,613 | -4% | -$1.59M |
|
2
SPDR Gold Trust
GLD
$107B
| $18.3M | 3.74% | 102,509 -25,693 | -20% | -$4.58M |
|
|
SPRB
3
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $15.5M | 3.17% | +636,653 | New | +$15.5M |
|
4
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $15M | 3.07% | 864,056 -180,105 | -17% | -$3.13M |
|
|
ALBO
5
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $13.3M | 2.72% | 354,210 -124,414 | -26% | -$4.67M |
|
6
HCA Healthcare
HCA
$94.5B
| $13.3M | 2.72% | 80,745 -25,187 | -24% | -$4.14M |
|
|
7
AstraZeneca
AZN
$248B
| $13.1M | 2.69% | +263,000 | New | +$13.1M |
|
8
Cigna
CI
$80.3B
| $13M | 2.65% | 62,265 -19,150 | -24% | -$3.99M |
|
9
Cencora
COR
$56.5B
| $12.5M | 2.56% | 127,781 -36,090 | -22% | -$3.53M |
|
|
WBA
10
DELISTED
Walgreens Boots Alliance
WBA
| $12.3M | 2.52% | 308,686 +8,592 | +3% | +$343K |
|
|
HRC
11
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $12.1M | 2.47% | 123,198 -76,702 | -38% | -$7.51M |
|
|
12
Universal Health Services
UHS
$11.6B
| $11.1M | 2.28% | +80,843 | New | +$11.1M |
|
|
13
Sanofi
SNY
$121B
| $10.7M | 2.19% | +220,201 | New | +$10.7M |
|
|
14
Amgen
AMGN
$155B
| $9.2M | 1.88% | +40,000 | New | +$9.2M |
|
|
15
AMN Healthcare
AMN
$796M
| $8.91M | 1.82% | 130,598 -141,635 | -52% | -$9.67M |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.84M | 1.81% | 100,844 -93,900 | -48% | -$8.23M |
|
17
Mirum Pharmaceuticals
MIRM
$3.71B
| $8.64M | 1.77% | +494,743 | New | +$8.64M |
|
|
18
Cardinal Health
CAH
$35.5B
| $8.31M | 1.7% | 155,217 -167,263 | -52% | -$8.96M |
|
|
19
McKesson
MCK
$85.4B
| $8.26M | 1.69% | 47,462 -70,987 | -60% | -$12.3M |
|
|
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.24M | 1.48% | 98,901 -48,599 | -33% | -$3.56M |
|
21
Becton Dickinson
BDX
$55.3B
| $6.84M | 1.4% | 27,314 +10,741 | +65% | +$2.69M |
|
22
Teva Pharmaceuticals
TEVA
$21.1B
| $6.66M | 1.36% | 690,386 -261,305 | -27% | -$2.52M |
|
|
SOLY
23
DELISTED
Soliton, Inc.
SOLY
| $6.62M | 1.36% | 862,405 -162,595 | -16% | -$1.25M |
|
24
Vertex Pharmaceuticals
VRTX
$100B
| $6.19M | 1.27% | +26,200 | New | +$6.19M |
|
25
Orthofix Medical
OFIX
$592M
| $5.95M | 1.22% | 138,525 -79,392 | -36% | -$3.41M |
|